FDA Inspection 1265673 — Kulkanya Chokephaibulkit
The FDA completed an inspection of Kulkanya Chokephaibulkit on March 13, 2025 in Bangkok. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bangkok (Thailand)
Additional Details
Clinical Investigator (CI)